-
Pilot Study of Behavioral Activation Treatment for Negative Symptoms in Older Adults With Schizophrenia Spectrum Disorder
-
Biomarkers in Schizophrenia: Current Approaches and New Developments—A Literature Review
-
Nuances of Gender Identity for a Transgender Patient Receiving Inpatient Treatment for Paranoid Schizophrenia: A Case Study
-
“Dream Insertion”: A Case Report of a Novel Psychotic Symptom in a Male Inpatient With Treatment Resistant Schizophrenia
-
Characterisation of the axon initial segment and intrinsic excitability in the sub-acute phase post-ischaemic stroke
-
The new German evidence‐ and consensus‐based schizophrenia guideline
-
What does it take to make real‐world changes in schizophrenia care?
-
Towards an integrative and personalized care across the stages of schizophrenia spectrum disorders
-
Interventions in schizophrenia should be transdiagnostic, biologically informed, individualized, and disease modifying
-
The problem of recognition of clinical high‐risk states is hampering the prevention of schizophrenia
-
Primary Somatosensory to Motor Cortex Microstructural Connectivity Predicts the Mu‐Rhythm Phase Effect on Corticospinal Excitability: An EEG‐TMS Study
-
Using Transcranial Magnetic Stimulation (TMS) to Compare Cortical Excitability Among Depressed Patients, Sleep-Deprived Controls, and Rested Controls
-
Aerobic Exercise for Cognitive and Functional Enhancement in Schizophrenia: Evidence, Mechanisms, and Practical Recommendations
-
Hydrogen Gas Therapy in Schizophrenia: Potential Neuroprotective Effects From an Animal Study
-
Insights into the origin of DNA methylation differences between monozygotic twins discordant for schizophrenia
-
Effectiveness of Electroconvulsive Therapy in the Remission of Malignant Catatonia Associated With Schizophrenia: A Case Report
-
Quality of Life After Psychosis: Surviving Schizophrenia and Making a Full Emotional Recovery
-
Managing Recurrent Postictal Worsening of Psychosis in Clozapine-Treated Schizophrenia: A Case Report
-
A Systematic Review of the Magnetic Resonance Imaging Literature Investigating the Deficit Syndrome in Schizophrenia
-
Association Between Frontotemporal Atrophy and Cognitive Impairment in Patients with Schizophrenia Based on Computed Tomography Imaging
-
Comparison of Neurocognitive Effects of Blonanserin, Olanzapine, Aripiprazole, and Risperidone in Drug-Naïve First-Episode Schizophrenia
-
Mitochondrial complex I and III gene mRNA levels in schizophrenia, and their relationship with clinical features
-
The Global Burden of Schizophrenia: Findings from the 2021 Global Burden of Diseases, Injuries, and Risk Factors Study
-
A Qualitative Investigation of the Experience of Taking Xanomeline and Trospium Chloride for Schizophrenia, Part 1: Perceived Impact on Symptoms
